Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Association of Current Tobacco Status With Pain and Symptom Severity in Fibromyalgia Patients.
Croghan IT, Hurt RT, Ganesh R, Bhagra O, Fischer KM, Vincent A, Hays JT, Bierle DM, Schroeder DR, Fuehrer DL, Nanda S. Croghan IT, et al. Among authors: bierle dm. Mayo Clin Proc Innov Qual Outcomes. 2021 May 26;5(3):614-624. doi: 10.1016/j.mayocpiqo.2021.03.008. eCollection 2021 Jun. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34195553 Free PMC article.
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.
Ganesh R, Pawlowski CF, O'Horo JC, Arndt LL, Arndt RF, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan PJ, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Ganesh R, et al. Among authors: bierle dm. J Clin Invest. 2021 Oct 1;131(19):e151697. doi: 10.1172/JCI151697. J Clin Invest. 2021. PMID: 34411003 Free PMC article.
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
Razonable RR, Pawlowski C, O'Horo JC, Arndt LL, Arndt R, Bierle DM, Borgen MD, Hanson SN, Hedin MC, Lenehan P, Puranik A, Seville MT, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Ganesh R. Razonable RR, et al. Among authors: bierle dm. EClinicalMedicine. 2021 Oct;40:101102. doi: 10.1016/j.eclinm.2021.101102. Epub 2021 Aug 30. EClinicalMedicine. 2021. PMID: 34485873 Free PMC article.
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
Ganesh R, Philpot LM, Bierle DM, Anderson RJ, Arndt LL, Arndt RF, Culbertson TL, Destro Borgen MJ, Hanson SN, Kennedy BD, Kottke BB, Larsen JJ, Ramar P, Rosedahl JK, Seville MT, Speicher LL, Tulledge-Scheitel SM, Wilker CG, Razonable RR. Ganesh R, et al. Among authors: bierle dm. J Infect Dis. 2021 Oct 28;224(8):1278-1286. doi: 10.1093/infdis/jiab377. J Infect Dis. 2021. PMID: 34279629 Free PMC article.
A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities.
Tulledge-Scheitel S, Bell SJ, Larsen JJ, Bierle DM, Takahashi P, Moehnke DE, Destro Borgen MJ, Springer DJ, Reinschmidt KJ, Baumbach LJ, Matoush JA, Heyliger A, Hanson SN, Razonable RR, Ganesh R. Tulledge-Scheitel S, et al. Among authors: bierle dm. J Am Geriatr Soc. 2021 Apr;69(4):868-873. doi: 10.1111/jgs.17090. Epub 2021 Mar 5. J Am Geriatr Soc. 2021. PMID: 33619724 Free PMC article.
37 results